Erratum: Different apoptosis modalities in periprosthetic membranes (Journal of Biomedical Materials Research (2010) 92A (175-184) DOI: 10.1002/jbm.a.32349);Different apoptosis modalities in periprosthetic membranes

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 1, 2010, Pages 175-184

  Sabbatini, Maurizio ^a   Piffanelli, Valentina ^a   Boccafoschi, Francesca ^a   Gatti, Silvia ^a   Renò, Filippo ^a   Bosetti, Michela ^a   Leigheb, Massimiliano ^a   Massè, Alessandro ^b   Mario, Cannas ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Caspase; Cell death; Periimplant membrane; Prosthesis loosening

Indexed keywords

ARTHROPLASTY; BINARY ALLOYS; CELL CULTURE; CELL PROLIFERATION; COBALT ALLOYS; FIBROBLASTS; MACROPHAGES; MEMBRANES; METAL IMPLANTS; TISSUE; TITANIUM ALLOYS; WEAR DEBRIS;

APOPTOTIC; CASPASES; CEMENTLESS PROSTHESIS; IMMUNOHISTOCHEMISTRY; JOINT ARTHROPLASTY; LEUCOCYTES; PERIIMPLANT MEMBRANE; PROSTHESIS LOOSENING; REVISION SURGERY; TOTAL HIP JOINTS;

CELL DEATH;

CASPASE 3; CASPASE 6; CASPASE 9; CHLORDANE; CHROMIUM; COBALT; KI 67 ANTIGEN; PROTEIN BAX; TITANIUM;

AGED; APOPTOSIS; ARTICLE; CELL DEATH; CELL RENEWAL; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; FIBROBLAST; HIP ARTHROPLASTY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION; MALE; NICK END LABELING; PROSTHESIS LOOSENING; PROTEIN LOCALIZATION; SYNOVIUM;

EID: 73549109415     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32880     Document Type: Erratum

References (58)

1. Thornhill TS, Ozuna RM, Shortkroff S, Keller K, Sledge CB, Spector M. Biochemical and histological evaluation of the synovial-like tissue around failed (loose) total joint replacement protheses in human subjects and canine model. Biomaterials 1990;11:69-72.
2. Perry M, Mourtuza FY, Ponsford FM, Elson CJ, Atkins RM, Learmonth D. Properties of tissue from around cemented joint implants with erosive and/or linear osteolysis. Arthroplasty 1997;12:670-676.
3. Jasty M, Smith E. Wear particles of total joint replacements and their role in periprosthetic osteolysis. Curr Opin Rheumathol 1992;4:204-209.
4. Murray DW, Rushton N. Macrophages stimulate bone resorption when they phagocytose particles. J Bone Joint Surg Br 1990;72:988-992.
5. Wang J, Harada Y, Doppalapudi VA, Goldring SR. Factors regulating the cell responses to orthopedic implant particulate debris. In: Galante J, Rosenberg AG, Callaghan JJ, editors. Total Revision Surgery. New York: Raven Press; 1995. pp 109-117.
6. Ingham E, Green TR, Stone MH, Kowalski R, Watkins N, Fisher J. Production of TNF-a and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 2000;21:1005-1013.
7. Horowitz SM, Purdon MA. Mediator interactions in macrophage/ particulate bone resorption. J Biomed Mater Res 1995;29:477-484.
8. Green TR, Fischer J, Stone M, Wroblewski BM, Ingham E. Polyethylenee particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 1998;19:2297-2303.
9. Granchi D, Ciapetti G, Stea S, Savarino L, Filippini F, Sudanese A, Zinghi G, Montanaro L. Cytokine release in mononuclear cells of patients with Co-Cr hip prosthesis. Biomaterials 1999;20:1079-1086.
10. Konttinen YT, Zhao D, Beklen A, Ma G, Akagi M, Kivalä-Rajamäki M, Ashammakhi N, Santavirta S. The microenvironment around total hip replacement prostheses. Clin Orthoped Relat Res 2005;430:28-38.
11. Thomsen P, Gretzer C. Macrophage interactions with modified material surfaces. Curr Opin Solid St 2001;5:163-176.
12. Mandelin J, Li TF, Hukkanen M, Liljestrom M, Salo J, Santavirta S, Konttinen YT. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kB ligand, osteoprotegerin, and cathepsin K. J Reumatol 2005;32:713-720.
13. Bosetti M, Massè A., Navone R, Cannas M. Biochemical and histological evaluation of human synovial-like membrane around failed total hip replacement protheses during in vitro mechanical loading. Int Mat Sci: Mat Med 2001;12:693-698.
14. Sabokbar A, Itonaga I, Sun SG, Kudo O, Athanasou NA. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. J Orthop Res 2005;23:511-519.
15. Koreny T, Tunyogi-Csapo M, Gàl I, Vermes C, Jacobs JJ Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum 2006;54:3221-3232.
16. Huk OL, Zulor DJ, Ralston W, Lisbona A, Petit A. Apoptosis in interface membranes of aseptically loose total hip arthoplasty. J Mat Sci Mat Med 2001;12:653-658.
17. Zhang XS, Revell PA. In situ localization of apoptotic changes in the interface membrane of aseptically loosed orthopaedic implants. J Mat Sci Mat Med 1999;10:879-883.
18. Stea S, Visentin M, Granchi D, Cenni E, Ciapetti G, Sudanese A, Toni A. Apoptosis in peri-implant tissue. Biomaterials 2000;21:1393-1398.
19. Renò F, Sabbatini M, Massè A, Bosetti M, Cannas M. Fibroblast apoptosis and caspase-8 activation in aseptic loosening. Biomaterials 2003;24:3941-3946.
20. Puskas BL, Menke NE, Huie P, Song Y, Ecklund K, Trinidade MCD, Smith RL, Goodman SB. Expression of nitric oxide, peroxynitrite, and apoptosis in loose total hip replacements. J Biomed Mater Res A 2003;66:541-549.
21. Ward C, Rossi AG, Haslett C, Dransfield I. Apoptosis: future perspectives. Essays Biochem 2003;39:155-162.
22. Santavirta S, Xu J-W, Hietanen J, Eponis A, Sorsa T, Kontio R, Konttinen YT. Activation of periprosthetic connective tissue in aseptic loosening of total hip replacement. Clin Orthoped Relat Res 1998;352:16-24.
23. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. Apoptosis in sepsis: A new target for therapeutic exploration. FASEB J 2001;15:879-892.
24. Charriaut-Marianque C, Ben Ari Y. A cautionary note on the use of TUNEL stain to determine apoptosis. Neuroreport 1995;7:61-64.
25. Zeuner A, Eramo A, Peschle C, De Maria R. Caspase activation without death. Cell Death Diff 1999;6:1075-1080.
26. Borner C, Monney L. Apoptosis without caspases: An inefficient molecular guillotine? Cell Death Diff 1999;6:497-507.
27. Johnson DE. Noncaspase proteases in apoptosis. Leukemia 2000;14:1695-1703.
28. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic formof programmed cell death. PNAS 2000;97:14376-14381.
29. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1326.
30. Formichi P, Radi E, Battisti C, Tarquini E, Leonini A, Di Stefano A, Federico A. Human fibroblasts undergo oxidative stress-induced apoptosis without internucleosomal DNA fragmentation. J Cell Physiol 2006;208:289-297.
31. Cui Q, Yu JH, Wu JN, Tasiro S, Onodera S, Minami M, Ikejima T. p53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9- dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin 2007;28:1057-1066.
32. Schwerk C, Schulze-Osthoff K. Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem Pharmacol 2003;66:1453-1458.
33. Harada S, Grant S. Apoptosis regulators. Rev Clin Exp Hematol 2003;7:110-138.
34. Kim R, Emi K, Tanabe S, Murakami Y, Uchida KA. Regulation and interplay of apoptotic and non-appoptotic cell death. J Pathol 2006;208:31-326.
35. De Lee JG, Charney G. Radiological demarcation of cemented sockets in total hip replacements. Clin Orthop 1976;121:20-32.
36. Smith DW, Day TA. Neurochemical identification of fos-positive neurons using two-colour immunoperoxidase staining. J Neurosci Methods 1993;47:73-83.
37. Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, Harris WH. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Surg Am 1993;75:863-879.
38. Green TR, Fischer J, Matthews JB, Stone M, Ingham E. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylenee particles. J Biomed Mater Res 2000;53:490-497.
39. Catelas I, Petit A, Vali H, Fragiskatos C, Meilleur R, Zukor DJ, Antoniou J, Huk OL. Quantitative analysis of macrophage apoptosis vs. necrosis induced by cobalt and chromium ions in vitro. Biomaterials 2005;26:2441-2453.
40. Puleo DA, Huh WW. Acute toxicity of metal ions in cultures of osteogenic cells derived from bone stromal cells. J Appl Biomater 1995;6:109-116.
41. Granchi D, Ciapetti G, Savarino L, Stea S, Cavedagna D, Donati ME, Pizzoferrato A. Assessment of metal extract toxicity on human lymphocytes cultured in vitro. J Biomed Mater Res 1996;31:183-191.
42. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: Apoptosis, necrosis and reactive oxygen damage. Oncogene 1999;18:7719-7730.
43. Kitanaka C, Kuchino Y. Caspase-indipendent programmed cell death with necrotic morphology. Cell Death Diff 1999;6:508-515.
44. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007;9:550-555.
45. Evans EM, Freeman MAR, Miller AJ, Vernon-Roberts B, Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement. J Bone Surg 1974;56B:626-642.
46. Glant TT, Jacobs JJ, Mikecz K, Yao J, Chubinskaya S, Williams JM, Urban RL, Shanbhaq AS, Lee SH, Sumner DR. Particulate induced, prostaglandine and cytokines-mediated bone resorbition in an experimental system and in failed joint replacements. Am J Ther 1996;3:27-41.
47. Yang RS, Liu TK. Immunohistochemical analysis of matrix proteolytic enzymes in the peroprosthetic tissue in the patients with loosening prostheses. Tohoku J exp Med 1998;184:99-111.
48. Yokohama Y, Matsumoto T, Hirakawa M, Kuroi Y. Fujimoto N, Imai K, Okada Y. Production of matrix metalloproteinases at bone-implant interface in loose total hip replacements. Lab Invest 1995;73:899-911.
49. Wagner S, Gollwitzer H, Wernike D, Langer R, Siebenrock KA, Hofstetter W. Interface membrane fibroblasts around aseptically loosened endoprotheses express MMP-13. J Orthoped Res 2008;26:143-152.
50. Mitsiades N, Poulaki V, Mitsiades CS, Anderson KC. Induction of tumor cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug. Expert Opin Investig Drugs 2001;10:1075-1084.
51. Ayala A, Chaudry IH Immune dysfunction in murine polymicrobial sepsis: Mediators, macrophages, lymphocytes and apoptosis. Shock 1996;6(S1):S27-S38.
52. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomez RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Cytokine profiles as makers of disease severity in sepsis: A multiplex analysis. Crit Care 2007;11:R49-R56.
53. Tinsley KW, Cheng SL, Buchman TG, Chang KC, Hui JJ, Swanson PE, Karl IE, Hotchkiss RS. Caspases -2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis. Shock 2000;13:1-7.
54. Guo RF, Huber-Lang M, Wang X, Sarma V, Padgaonkar VA, Craig RA, Riedemann NC, McClintok SD, Hlaing T, Shi MM, Ward PA. Protective effects of anti-C5a in sepsisinduced thymocyte apoptosis. J Clin Invest 2000;106:1271-1280.
55. Cowling V, Downward J. Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: Absolute requirement for removal of caspase-6 prodomain. Cell Death Diff 2002;9:1046-1056.
56. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Diff 2007;14:44-55.
57. Collins FM. Cellular antimicrobial immunity. CRC Crit Rev Microbiol 1978;7:27-91.
58. Tunyogi-Csapo M, Koreny T, Vermes C, Galante JO, Jacobs JJ, Giant TT. Role of fibroblasts and fibroblast-derived growth factors in periprosthetic angiogenesis. J Orthoped Res 2007;25:1378-1388.